FARSLB Antibodies

Santa Cruz Biotechnology delivers a wide array of FARSLB Antibodies for investigating the function and regulation of FARSLB. FARSLB Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FARSLB, or phenylalanyltRNA synthetase, plays a crucial role in protein synthesis by catalyzing the attachment of phenylalanine to its corresponding tRNA. This process is essential for the accurate translation of genetic information into functional proteins, making FARSLB vital for cellular function and metabolism. Research has shown that FARSLB activity influences various cellular pathways and signaling mechanisms. Understanding FARSLB expression patterns and interactions can provide valuable insights into disease mechanisms and potential therapeutic strategies. Dysregulation of FARSLB has been implicated in various diseases, highlighting its significance in human health. Ongoing studies continue to reveal new aspects of FARSLB biology and its impact on cellular processes. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of FARSLB and its role in health and disease.